Webcast - Q2 Earnings Announcement
Date & Time: Thursday, August 14, 2014 - 8:30 AM ET
Concordia Healthcare Corp.
Concordia operates a healthcare business that includes the management and acquisition of legacy pharmaceutical products and acquires and develops orphan drugs both with patent life and exclusivity remaining (pre-legacy), and products that have reached full maturity but continue on a predictable revenue generation path, collectively referred to as legacy products. Regardless of stage of the life cycle the targeted products have a well-established record of safety and efficacy and a history of stable, predictable prescription demand.